NEOGENOMICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.52 USD | +4.01% |
|
+4.84% | -10.26% |
| 12:09pm | North American Morning Briefing : Stock Futures -3- | DJ |
| 04-30 | Needham Lowers Price Target on NeoGenomics to $19 From $24 Due to Peer Multiple Compression, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical & Diagnostic Laboratories
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.78B | - | |||||
| 8.22B | ||||||
| 3.73B | - | - | ||||
| 2.46B | ||||||
| 2.46B | ||||||
| 2.36B |
- Stock Market
- Equities
- NEO Stock
- Charts NeoGenomics, Inc.
- Sector Chart
